All lobbying filings

Bluebird Strategies

Bluebird Strategies filed a Q4 report for Celltrion USA, Inc. on January 21, 2026.

Lobbying for Celltrion USA, Inc. · Biopharmaceutical Company

As filed: BLUEBIRD STRATEGIES for CELLTRION USA, INC.

All filings by Bluebird Strategies · Everything Celltrion USA, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem